An Isotype-specific Activator of Major Histocompatibility Complex (MHC) Class II Genes That Is Independent of Class II Transactivator

Yazar: Douhan, John, Lieberson, Rebecca, Knoll, Joan H.M., Zhou, Hong, Glimcher, Laurie H.
Baskı/Yayın Bilgisi 1997

A roadmap to evaluate the proteome-wide selectivity of covalent kinase inhibitors

Yazar: Lanning, Bryan R., Whitby, Landon R., Dix, Melissa M., Douhan, John, Gilbert, Adam M., Hett, Erik C., Johnson, Theodore O., Joslyn, Chris, Kath, John C., Niessen, Sherry, Roberts, Lee R., Schnute, Mark E., Wang, Chu, Hulce, Jonathan J., Wei, Baoxian, Whiteley, Laurence O., Hayward, Matthew M., Cravatt, Benjamin F.
Baskı/Yayın Bilgisi 2014

Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning

Yazar: Schnute, Mark E., Benoit, Stephen E., Buchler, Ingrid P., Caspers, Nicole, Grapperhaus, Margaret L., Han, Seungil, Hotchandani, Rajeev, Huang, Nelson, Hughes, Robert O., Juba, Brian M., Kim, Kyung-Hee, Liu, Erica, McCarthy, Erin, Messing, Dean, Miyashiro, Joy S., Mohan, Shashi, O’Connell, Thomas N., Ohren, Jeffrey F., Parikh, Mihir D., Schmidt, Michelle, Selness, Shaun R., Springer, John R., Thanabal, Venkataraman, Trujillo, John I., Walker, Daniel P., Wan, Zhao-Kui, Withka, Jane M., Wittwer, Arthur J., Wood, Nancy L., Xing, Li, Zapf, Christoph W., Douhan, John
Yayımlandı ACS Med Chem Lett (2018)